๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
62 medicines starting with โ€œUโ€
MedicineActive substanceLicence holderStatus
Ucedane 200 mg dispersible tablets
EU/1/17/1202/001-002
Carglumic acid Eurocept International BV โ€”
Ulipristal Acetate Rowex 30 mg film-coated tablets
PA0711/292/001
Ulipristal acetate Rowex Limited, Marketed
Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/13/862/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited โ€”
Ultiva 1 mg Powder for Concentrate for Solution for Infusion
PA1691/032/001
Remifentanil hydrochloride Aspen Pharma Trading Limited Marketed
Ultiva 2 mg Powder for Concentrate for Solution for Infusion
PA1691/032/002
Remifentanil Aspen Pharma Trading Limited Marketed
Ultiva 5 mg Powder for Concentrate for Solution for Infusion
PA1691/032/003
Remifentanil Aspen Pharma Trading Limited Marketed
Ultomiris 1 100 mg/11 mL concentrate for solution for infusion
EU/1/19/1371/003
RAVULIZUMAB Alexion Europe S.A.S. โ€”
Ultomiris 300 mg/3 mL concentrate for solution for infusion
EU/1/19/1371/002
RAVULIZUMAB Alexion Europe S.A.S. โ€”
Ultra-TechneKow FM 2.15-43.00 GBq radionuclide generator
PA0690/017/001
Sodium molybdate (99mo) Curium Netherlands B.V. Marketed
Ultraproct 0.92 mg/g + 0.9 5mg/g + 5 mg/g Rectal Ointment
PA22650/004/001
Fluocortolone pivalate, Fluocortolone caproate, Cinchocaine Hydrochloride Karo Pharma AB Marketed
Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/14/917/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited โ€”
Uniflu Plus with Vitamin C Tablets
PA1113/006/001
Paracetamol, Codeine phosphate hemihydrate, Diphenhydramine hydrochloride, Phenylephrine hydrochloride, Caffeine Phoenix Labs Marketed
Uniflu with Vitamin C Tablets
PA1113/005/001
Caffeine, Diphenhydramine hydrochloride, Paracetamol, Phenylephrine hydrochloride, Ascorbic acid Phoenix Labs Marketed
UNIPHYLLIN 200 mg Prolonged-Release Tablets
PA23369/003/001
Theophylline Ennogen Healthcare (Europe) Limited Not marketed
UNIPHYLLIN 300 mg Prolonged-Release Tablets
PA23369/003/002
Theophylline Ennogen Healthcare (Europe) Limited Not marketed
UNIPHYLLIN 400 mg Prolonged-Release Tablets
PA23369/003/003
Theophylline Ennogen Healthcare (Europe) Limited Not marketed
Uplizna 100 mg concentrate for solution for infusion
EU/1/21/1602/001
Inebilizumab Amgen Europe B.V., โ€”
Upstaza 2.8 ร— 10^11 vector genomes/0.5 mL solution for infusion
EU/1/22/1653/001
Eladocagene Exuparvovec PTC Therapeutics International Limited โ€”
Uptravi 100 microgram film-coated tablets
EU/1/15/1083/012-013
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1000 microgram film-coated tablets
EU/1/15/1083/007
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1200 microgram film-coated tablets
EU/1/15/1083/008
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1400 microgram film-coated tablets
EU/1/15/1083/009
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1600 microgram film-coated tablets
EU/1/15/1083/010
Selexipag Janssen-Cilag International NV โ€”
Uptravi 200 microgram film-coated tablets
EU/1/15/1083/001-003
Selexipag Janssen-Cilag International NV โ€”
Uptravi 400 microgram film-coated tablets
EU/1/15/1083/004
Selexipag Janssen-Cilag International NV โ€”
Uptravi 600 microgram film-coated tablets
EU/1/15/1083/005
Selexipag Janssen-Cilag International NV โ€”
Uptravi 800 microgram film-coated tablets
EU/1/15/1083/006
Selexipag Janssen-Cilag International NV โ€”
Urispas 200 mg Film-coated Tablets
PA1404/001/001
Flavoxate hydrochloride Recordati Ireland Limited Marketed
Urografin 30 % w/v Solution for infusion
PA1410/012/001
Sodium amidotrizoate, Meglumine amidotrizoate, Sodium hydroxide Bayer Limited Marketed
Uromitexan 100mg/ml Solution for Injection or Infusion
PA2299/024/001
Mesna Baxter Holding B.V. Marketed
Uromitexan tablets 400 mg
PA2299/024/002
Mesna Baxter Holding B.V. Marketed
Uromitexan Tablets 600mg
PA2299/024/003
Mesna Baxter Holding B.V. Marketed
Urorec 4 mg hard capsules
EU/1/09/608/1-7
Silodosin Recordati Ireland Limited โ€”
Urorec 8 mg hard capsules
EU/1/09/608/8-14
Silodosin Recordati Ireland Limited โ€”
Ursodeoxycholic Acid 250 mg capsules, hard
PA1142/018/001
Ursodeoxycholic acid Amdipharm Limited Not marketed
Ursofalk 250 mg hard capsules
PPA0465/183/001
Ursodeoxycholic acid PCO Manufacturing Ltd. โ€”
Ursofalk 250 mg Hard Capsules
PA0573/005/001
Ursodeoxycholic acid Dr. Falk Pharma GmbH Marketed
Ursofalk 250 mg Hard Capsules
PPA1463/144/001
Ursodeoxycholic acid IMED Healthcare Ltd., โ€”
Ursofalk 250 mg/5 ml Suspension
PA0573/005/002
Ursodeoxycholic acid Dr. Falk Pharma GmbH Marketed
Ursofalk 500 mg film-coated tablets
PPA0465/183/002
Ursodeoxycholic acid PCO Manufacturing Ltd. โ€”
Ursofalk 500 mg film-coated tablets
PPA1463/144/002
Ursodeoxycholic acid IMED Healthcare Ltd., โ€”
Ursofalk 500mg film-coated tablets
PA0573/005/003
Ursodeoxycholic acid Dr. Falk Pharma GmbH Marketed
Ursogrix 250 mg hard capsules
PA22992/002/001
Ursodeoxycholic acid AS Grindeks โ€”
Usgena 130 mg concentrate for solution for infusion
EU/1/25/1987/005
Ustekinumab Stada Arzneimittel AG โ€”
Usgena 45 mg solution for injection
EU/1/25/1987/001
Ustekinumab Stada Arzneimittel AG โ€”
Usgena 45 mg solution for injection in pre-filled syringe
EU/1/25/1987/002
Ustekinumab Stada Arzneimittel AG โ€”
Usgena 90 mg solution for injection in pre-filled syringe
EU/1/25/1987/003-004
Ustekinumab Stada Arzneimittel AG โ€”
Usrenty 130 mg concentrate for solution for infusion
EU/1/25/1973/004
Ustekinumab Biocon Biologics Ireland Limited โ€”
Usrenty 45 mg solution for injection
EU/1/25/1973/001
Ustekinumab Biocon Biologics Ireland Limited โ€”
Usrenty 45 mg solution for injection in pre-filled syringe
EU/1/25/1973/002
Ustekinumab Biocon Biologics Ireland Limited โ€”
1 2 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.